Annotation analysis for testing drug safety signals using unstructured clinical notes
暂无分享,去创建一个
Cédrick Fairon | Nigam H. Shah | Paea LePendu | Srinivasan Iyer | N. Shah | P. LePendu | Srini Iyer | Cedric Fairon
[1] George Hripcsak,et al. A statistical methodology for analyzing co-occurrence data from a large sample , 2007, J. Biomed. Informatics.
[2] Mark A. Musen,et al. Enabling enrichment analysis with the Human Disease Ontology , 2011, J. Biomed. Informatics.
[3] Stephanie Chung,et al. The FDA drug safety surveillance program: adverse event reporting trends. , 2011, Archives of internal medicine.
[4] J Starren,et al. Architectural requirements for a multipurpose natural language processor in the clinical environment. , 1995, Proceedings. Symposium on Computer Applications in Medical Care.
[5] S. Shoor,et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study , 2005, The Lancet.
[6] Siddhartha R. Dalal,et al. Using information mining of the medical literature to improve drug safety , 2011, J. Am. Medical Informatics Assoc..
[7] Daniel L. Rubin,et al. Comparison of concept recognizers for building the Open Biomedical Annotator , 2009, BMC Bioinformatics.
[8] Rong Chen,et al. Ontology-driven indexing of public datasets for translational bioinformatics , 2009, BMC Bioinformatics.
[9] Christopher G. Chute,et al. BioPortal: ontologies and integrated data resources at the click of a mouse , 2009, Nucleic Acids Res..
[10] Sunghwan Sohn,et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications , 2010, J. Am. Medical Informatics Assoc..
[11] Nigam H. Shah,et al. Using Temporal Patterns in Medical Records to Discern Adverse Drug Events from Indications , 2012, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[12] M. Schuemie,et al. Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project , 2011, Pharmacoepidemiology and drug safety.
[13] Carol Friedman,et al. Mining multi-item drug adverse effect associations in spontaneous reporting systems , 2010, BMC Bioinformatics.
[14] Olivier Bodenreider,et al. The Unified Medical Language System (UMLS): integrating biomedical terminology , 2004, Nucleic Acids Res..
[15] G Hripcsak,et al. Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System , 2011, Clinical pharmacology and therapeutics.
[16] Carol Friedman,et al. Mining electronic health records for adverse drug effects using regression based methods , 2010, IHI.
[17] D. Bates,et al. The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .
[18] J. Avorn,et al. A review of uses of health care utilization databases for epidemiologic research on therapeutics. , 2005, Journal of clinical epidemiology.
[19] J. Avorn,et al. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data , 2009, Epidemiology.
[20] Xiaoyan Wang,et al. Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. , 2009, Journal of the American Medical Informatics Association : JAMIA.
[21] D. Dore,et al. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. , 2009, Current medical research and opinion.
[22] J. Overhage,et al. Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership , 2010, Annals of Internal Medicine.
[23] Prakash M. Nadkarni,et al. Drug safety surveillance using de-identified EMR and claims data: issues and challenges , 2010, J. Am. Medical Informatics Assoc..
[24] Purvesh Khatri,et al. Ontological analysis of gene expression data: current tools, limitations, and open problems , 2005, Bioinform..
[25] Chitta Baral,et al. Discovering drug–drug interactions: a text-mining and reasoning approach based on properties of drug metabolism , 2010, Bioinform..
[26] Lucila Ohno-Machado,et al. Realizing the full potential of electronic health records: the role of natural language processing , 2011, J. Am. Medical Informatics Assoc..
[27] Prakash M. Nadkarni,et al. Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions , 2011, J. Am. Medical Informatics Assoc..
[28] Gil Alterovitz,et al. GO PaD: the Gene Ontology Partition Database , 2006, Nucleic Acids Res..
[29] Wendy W. Chapman,et al. A Simple Algorithm for Identifying Negated Findings and Diseases in Discharge Summaries , 2001, J. Biomed. Informatics.
[30] M J Goldacre,et al. Cancer and immune-mediated disease in people who have had meningococcal disease: record-linkage studies , 2008, Epidemiology and Infection.
[31] Patrick B. Ryan,et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases , 2010, J. Am. Medical Informatics Assoc..
[32] Dean F. Sittig,et al. Application of electronic health records to the Joint Commission's 2011 National Patient Safety Goals. , 2011, JAMA.
[33] Wendy W. Chapman,et al. ConText: An Algorithm for Identifying Contextual Features from Clinical Text , 2007, BioNLP@ACL.
[34] S D Small,et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. , 1998, JAMA.
[35] Neil R. Smalheiser,et al. Proceedings of the 1st ACM International Health Informatics Symposium , 2010, IHI 2010.
[36] D. Classen,et al. 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured. , 2011, Health affairs.
[37] A. Bate,et al. Quantitative signal detection using spontaneous ADR reporting , 2009, Pharmacoepidemiology and drug safety.
[38] Sébastien Paumier,et al. De la reconnaissance des formes linguistiques à l'analyse syntaxique , 2003 .
[39] Madeleine Udell,et al. Analyzing Patterns of Drug Use in Clinical Notes for Patient Safety , 2012, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.